Showing 3941-3950 of 19385 results for "".
Expert Opinions on Renal Compensation and Renal Functional Reserve
https://reachmd.com/programs/medical-industry-feature/renal-compensation-functional-reserve/39257/Learn more as Drs Jai Radhakrishnan and Leal C. Herlitz share expert perspectives on renal compensatory mechanisms and impact in glomerular diseases. Dr Radhakrishnan is a Professor of Medicine and the Director of Clinical Services of the Nephrology Division at Columbia University. Dr Herlitz is a rEvaluating Sleep Deprivation as a Risk Factor for Postpartum Depression
https://reachmd.com/programs/advances-in-womens-health/evaluating-sleep-deprivation-as-a-risk-factor-for-postpartum-depression/32751/While we don’t understand the pathophysiology of mental illnesses like postpartum depression, we do know a lot about its contributing factors. One such factor is sleep deprivation, which is why Dr. Nicole Leistikow is here to talk about the effects of sleep in postpartum women. Dr. Leistikow is an APractical Tips for GLP-1RA Therapy Success
https://reachmd.com/programs/cme/practical-tips-for-glp-1-ra-therapy-success/35830/Unlock expert insights on obesity as a chronic disease—tackle stigma, manage comorbidities, and optimize long-term care strategies.Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
https://reachmd.com/programs/project-oncology/nephrotoxicity-in-the-crosshairs-optimizing-renal-cancer-care-with-kidney-preservation/24477/Here’s an essential review of nephrotoxic mechanisms, personalized risk assessments, and tailored therapeutic interventions for renal cell carcinoma.Managing High-Risk Osteoporosis: Post-Hoc Findings on Abaloparatide
https://reachmd.com/programs/frontlines-osteoporosis/managing-high-risk-osteoporosis-post-hoc-findings-on-abaloparatide/32345/Abaloparatide has been gaining attention as a treatment option for patients with osteoporosis at very high risk of fracture. A recent post-hoc analysis of the ACTIVE trial, which examined how abaloparatide compares to teriparatide and placebo in reducing fractures and improving bone mineral density,Gene Therapy, the Future of Eye Care?
https://reachmd.com/programs/medical-industry-feature/gene-therapy-future-of-eye-care/37246/While anti-VEGF therapy can deliver vision gains with consistent, frequent injections in clinical trials, it may be challenging to sustain this in real-world practice.1 Ocular gene therapy could be a potential option for patients with neovascular age-related macular degeneration if approved. With thAddressing Barriers to Early Detection for Alzheimer's Disease
https://reachmd.com/programs/alzheimers-disease-towards-early-detection/addressing-barriers-early-detection-alzheimers-disease/8322/Dr. Marwan Sabbagh from the Barrow Neurological Institute discusses barriers to early detection for Alzheimer's and how to address them in practice.Balneotherapy Continued: A Future in US Dermatology?
https://reachmd.com/programs/practical-dermatology-type-ii-inflammation-journal-club/balneotherapy-continued-a-future-in-us-dermatology/54116/Practical Dermatology editorial board member Peter Lio, MD, and Karan Lal, DO, MS, FAAD, continue their discussion of the International Journal of Biometeorology article “Balneotherapy using thermal mineral water baths and dermatological diseases: a systematic review,” covering the evidence supportiChallenges in AI-Driven Dermatology: Understanding Current Limitations
https://reachmd.com/programs/clinicians-roundtable/challenges-in-ai-driven-dermatology-understanding-current-limitations/32934/While artificial intelligence tools for hair loss treatment are rapidly evolving, limitations on time, cost, and data integration still exist.Groundbreaking AI Models Transform Cardiovascular Diagnosis
https://reachmd.com/programs/medical-industry-feature/groundbreaking-ai-models-transform-cardiovascular-diagnosis/29925/Discover how new AI models are leveraging cardiac imaging to detect structural heart disease earlier and expand access to life-saving screening.